HIMS logo

HIMS

Hims & Hers Health Inc. Class A

$34.71
+$1.09(+3.24%)
22
Overall
20
Value
25
Tech
--
Quality
Market Cap
$9.60B
Volume
18.78M
52W Range
$23.97 - $72.98
Target Price
$47.92

Company Overview

Mkt Cap$9.60BPrice$34.71
Volume18.78MChange+3.24%
P/E Ratio76.2Open$33.54
Revenue$1.5BPrev Close$33.62
Net Income$126.0M52W Range$23.97 - $72.98
Div YieldN/ATarget$47.92
Overall22Value20
Quality--Technical25

No chart data available

About Hims & Hers Health Inc. Class A

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Sector: Health Care and Social Assistance
Industry: Offices of Physicians, Mental Health Specialists

Latest News

Hims & Hers (HIMS) Investors Keep the Faith as Stock Slides 15%

If you only glance at the share price, you might think the Hims & Hers Health ($HIMS) story has lost its spark. The stock has declined by more than...

Nikolaos Sismanis5 days ago

Hims & Hers Stock (HIMS) Plunges despite New ‘Affordable’ Healthcare Platform

Solomon Oladipupo10 days ago

Morgan Stanley Sticks to Their Hold Rating for Hims & Hers Health (HIMS)

TipRanks Auto-Generated Intelligence Newsdesk16 days ago

Hims & Hers Health (HIMS) Looks to Turn GLP-1 Hype Into Health Empire

Nikolaos Sismanis18 days ago

Hims & Hers Health, Inc. Reports Strong Growth and Strategic Optimism

TipRanks Auto-Generated Newsdesk19 days ago
ABCD
1SymbolPriceChangeVol
2HIMS$34.71+3.2%18.78M
3
4
5
6

Get Hims & Hers Health Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.